Analysis of masked mutations in familial adenomatous polyposis
Authors:
- Nickolas PapadopoulosNPNickolas Papadopoulos
- Gloria M. PetersenGPGloria M. Petersen
- Stephen B. GruberSGStephen B. Gruber
- Stanley R. HamiltonSHStanley R. Hamilton
- Francis M. GiardielloFGFrancis M. Giardiello
- Jill D. BrensingerJBJill D. Brensinger
- Bert VogelsteinBVBert Vogelstein
- Kenneth W. KinzlerKKKenneth W. Kinzler
Open Access
- 2 March 1999
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (5) , 2322-2326
Abstract
Familial adenomatous polyposis (FAP) is an autosomal-dominant disease characterized by the development of hundreds of adenomatous polyps of the colorectum. Approximately 80% of FAP patients can be shown to have truncating mutations of the APC gene. To determine the cause of FAP in the other 20% of patients, MAMA (monoallelic mutation analysis) was used to independently examine the status of each of the two APC alleles. Seven of nine patients analyzed were found to have significantly reduced expression from one of their two alleles whereas two patients were found to have full-length expression from both alleles. We conclude that more than 95% of patients with FAP have inactivating mutations in APC and that a combination of MAMA and standard genetic tests will identify APC abnormalities in the vast majority of such patients. That no APC expression from the mutant allele is found in some FAP patients argues strongly against the requirement for dominant negative effects of APC mutations. The results also suggest that there may be at least one additional gene, besides APC , that can give rise to FAP.Keywords
This publication has 39 references indexed in Scilit:
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βCurrent Biology, 1998
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTIONGastroenterology Clinics of North America, 1996
- NSAID-INDUCED POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTSGastroenterology Clinics of North America, 1996
- Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444Human Molecular Genetics, 1995
- Rapid Detection of Translation-Terminating Mutations at the Adenomatous Polyposis Coli (APC) Gene by Direct Protein Truncation TestGenomics, 1994
- Mutations of theAPC adenomatous polyposis coli) geneHuman Mutation, 1993
- Insertion/Deletion Polymorphism and Other Restriction Fragment Length Polymorphisms in the MCC GeneJapanese Journal of Cancer Research, 1992
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- Identification and characterization of the familial adenomatous polyposis coli geneCell, 1991